Edgar Filing: Colfax CORP

Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q



x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2016



¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number - 001-34045

Colfax Corporation

(Exact name of registrant as specified in its charter)




Delaware		54-1887631
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

420 National Business Parkway, 5th Floor Annapolis Junction, Maryland		20701
(Address of principal executive offices)		(Zip Code)

(301) 323-9000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer ¨

Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

As of September 30, 2016, there were 122,661,828 shares of the registrant’s common stock, par value $.001 per share, outstanding.

TABLE OF CONTENTS



	Page
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements	2
Condensed Consolidated Statements of Income	2
Condensed Consolidated Statements of Comprehensive Income (Loss)	3
Condensed Consolidated Balance Sheets	4
Condensed Consolidated Statement of Equity	5
Condensed Consolidated Statements of Cash Flows	6
Notes to Condensed Consolidated Financial Statements	7
Note 1. General	7
Note 2. Recently Issued Accounting Pronouncements	7
Note 3. Acquisitions	9
Note 4. Net Income Per Share	9
Note 5. Income Taxes	9
Note 6. Equity	10
Note 7. Inventories, Net	13
Note 8. Debt	13
Note 9. Accrued Liabilities	14
Note 10. Net Periodic Benefit Cost - Defined Benefit Plans	16
Note 11. Financial Instruments and Fair Value Measurements	17
Note 12. Commitments and Contingencies	19
Note 13. Segment Information	20
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3. Quantitative and Qualitative Disclosures About Market Risk	33
Item 4. Controls and Procedures	34

PART II - OTHER INFORMATION
Item 1. Legal Proceedings	35
Item 1A. Risk Factors	35
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	35
Item 3. Defaults Upon Senior Securities	35
Item 4. Mine Safety Disclosures	35
Item 5. Other Information	35
Item 6. Exhibits	36

SIGNATURES	37

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

Dollars in thousands, except per share amounts

(Unaudited)



	Three Months Ended				Nine Months Ended
	September 30, 2016		September 25, 2015		September 30, 2016		September 25, 2015

Net sales	$	879,204	$	969,144	$	2,713,296	$	2,905,589
Cost of sales	603,797		673,270		1,856,263		1,987,240
Gross profit	275,407		295,874		857,033		918,349
Selling, general and administrative expense	199,502		237,248		627,442		673,109
Asbestos coverage adjustment	8,226		—		8,226		—
Restructuring and other related charges	17,159		13,071		49,317		25,658
Operating income	50,520		45,555		172,048		219,582
Interest expense	6,792		10,857		24,623		37,150
Income before income taxes	43,728		34,698		147,425		182,432
Provision for income taxes	11,529		11,153		45,053		43,783
Net income	32,199		23,545		102,372		138,649
Less: income attributable to noncontrolling interest, net of taxes	4,229		5,186		12,033		15,107
Net income attributable to Colfax Corporation	$	27,970	$	18,359	$	90,339	$	123,542
Net income per share - basic and diluted	$	0.23	$	0.15	$	0.73	$	0.99

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

Dollars in thousands

(Unaudited)



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
Net income	$	32,199		$	23,545		$	102,372		$	138,649
Other comprehensive loss:
Foreign currency translation, net of tax of $462, $0, $2,898 and $0	(31,679		)	(145,177		)	(185,743		)	(217,418		)
Unrealized gain (loss) on hedging activities, net of tax of $(12,108), $1,641, $(13,807) and $16,069	9,146			(6,830		)	3,826			5,429
Changes in deferred tax related to pension and other post-retirement benefit cost	—			—			—			3,817
Amounts reclassified from Accumulated other comprehensive loss:
Net pension and other post-retirement benefit cost, net of tax of $476, $903, $1,974 and $3,574	871			1,813			3,579			5,887
Foreign currency translation adjustment resulting from Venezuela deconsolidation	2,378			—			2,378			—
Other comprehensive loss	(19,284		)	(150,194		)	(175,960		)	(202,285		)
Comprehensive income (loss)	12,915			(126,649		)	(73,588		)	(63,636		)
Less: comprehensive income (loss) attributable to noncontrolling interest	7,940			(6,790		)	16,968			(1,434		)
Comprehensive income (loss) attributable to Colfax Corporation	$	4,975		$	(119,859	)	$	(90,556	)	$	(62,202	)

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

Dollars in thousands, except share amounts

(Unaudited)



	September 30, 2016			December 31, 2015
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	191,660		$	197,469
Trade receivables, less allowance for doubtful accounts of $44,394 and $39,505	922,247			888,166
Inventories, net	423,905			420,386
Other current assets	265,429			253,744
Total current assets	1,803,241			1,759,765
Property, plant and equipment, net	632,219			644,536
Goodwill	2,632,433			2,817,687
Intangible assets, net	940,615			995,712
Other assets	533,884			515,219
Total assets	$	6,542,392		$	6,732,919

LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Current portion of long-term debt	$	6,082		$	5,792
Accounts payable	651,792			718,893
Accrued liabilities	416,973			391,659
Total current liabilities	1,074,847			1,116,344
Long-term debt, less current portion	1,379,058			1,411,755
Other liabilities	919,828			948,264
Total liabilities	3,373,733			3,476,363
Equity:
Common stock, $0.001 par value; 400,000,000 shares authorized; 122,661,828 and 123,486,425 issued and outstanding	123			123
Additional paid-in capital	3,192,788			3,199,267
Retained earnings	647,639			557,300
Accumulated other comprehensive loss	(867,610		)	(686,715		)
Total Colfax Corporation equity	2,972,940			3,069,975
Noncontrolling interest	195,719			186,581
Total equity	3,168,659			3,256,556
Total liabilities and equity	$	6,542,392		$	6,732,919

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENT OF EQUITY

Dollars in thousands, except share amounts and as noted

(Unaudited)



	Common Stock					Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Loss			Noncontrolling Interest			Total
	Shares		$ Amount			Additional Paid-In Capital			Retained Earnings		Accumulated Other Comprehensive Loss			Noncontrolling Interest			Total
Balance at January 1, 2016	123,486,425		$	123		$	3,199,267		$	557,300	$	(686,715	)	$	186,581		$	3,256,556
Net income	—		—			—			90,339		—			12,033			102,372
Distributions to noncontrolling owners	—		—			—			—		—			(7,830		)	(7,830		)
Other comprehensive (loss) income, net of tax of $(8.9) million	—		—			—			—		(180,895		)	4,935			(175,960		)
Stock repurchase	(1,000,000	)	(1		)	(20,811		)	—		—			—			(20,812		)
Common stock-based award activity	175,403		1			14,332			—		—			—			14,333
Balance at September 30, 2016	122,661,828		$	123		$	3,192,788		$	647,639	$	(867,610	)	$	195,719		$	3,168,659

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Dollars in thousands

(Unaudited)



	Nine Months Ended
	September 30, 2016			September 25, 2015

Cash flows from operating activities:
Net income	$	102,372		$	138,649
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and impairment charges	107,101			110,776
Stock-based compensation expense	13,920			11,886
Non-cash interest expense	3,126			10,099
Deferred income tax (benefit) provision	(1,171		)	15
Changes in operating assets and liabilities:
Trade receivables, net	(28,341		)	(38,972		)
Inventories, net	2,932			(20,967		)
Accounts payable	(67,771		)	3,710
Changes in other operating assets and liabilities	(30,314		)	(63,058		)
Net cash provided by operating activities	101,854			152,138

Cash flows from investing activities:
Purchases of fixed assets, net	(41,671		)	(32,729		)
Acquisition, net of cash received	—			(184,500		)
Net cash used in investing activities	(41,671		)	(217,229		)

Cash flows from financing activities:
Borrowings under term credit facility	—			750,000
Payments under term credit facility	(28,125		)	(1,223,497		)
Proceeds from borrowings on revolving credit facilities and other	659,469			1,328,332
Repayments of borrowings on revolving credit facilities and other	(676,257		)	(835,232		)
Proceeds from issuance of common stock, net	413			3,116
Repurchases of common stock	(20,812		)	—
Other	(7,830		)	(9,796		)
Net cash (used in) provided by financing activities	(73,142		)	12,923

Effect of foreign exchange rates on Cash and cash equivalents	7,150			(32,033		)
Decrease in Cash and cash equivalents	(5,809		)	(84,201		)
Cash and cash equivalents, beginning of period	197,469			305,448
Cash and cash equivalents, end of period	$	191,660		$	221,247

See Notes to Condensed Consolidated Financial Statements.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. General

Colfax Corporation (the “Company” or “Colfax”) is a diversified global industrial manufacturing and engineering company that provides gas- and fluid-handling and fabrication technology products and services to customers around the world principally under the Howden, ESAB and Colfax Fluid Handling brand names.

The Condensed Consolidated Financial Statements included in this quarterly report have been prepared by the Company in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States of America (“GAAP”) for interim financial statements.

The Condensed Consolidated Balance Sheet as of December 31, 2015 is derived from the Company’s audited financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been omitted in accordance with the SEC’s rules and regulations for interim financial statements. The Condensed Consolidated Financial Statements included herein should be read in conjunction with the audited financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015 (the “2015 Form 10-K”), filed with the SEC on February 16, 2016.

The Condensed Consolidated Financial Statements reflect, in the opinion of management, all adjustments, which consist solely of normal recurring adjustments, necessary to present fairly the Company’s financial position and results of operations as of and for the periods indicated. Significant intercompany transactions and accounts are eliminated in consolidation.

During the three months ended September 30, 2016, the Company determined that an other-than-temporary lack of exchangeability between the Venezuelan bolivar and U.S. dollar, due to government controls, has restricted the Company’s Venezuelan operations ability to pay dividends and satisfy other obligations denominated in U.S. dollars. In addition, other government-imposed restrictions affecting labor, production, and distribution are prohibiting the Company from controlling key operating decisions. These circumstances have caused the Company to no longer meet the accounting criteria of control in order to continue consolidating its Venezuelan operations. Therefore, the Company has deconsolidated the financial statements of its Venezuelan operations as of September 30, 2016. As a result of the deconsolidation, the Company recorded a charge of $2.4 million in Selling, general and administrative expense for the three and nine months ended September 30, 2016, substantially all of which related to accumulated foreign currency translation charges previously included in Accumulated other comprehensive loss. Due to loss of control, the Company has applied the cost method of accounting for its Venezuelan operations as of September 30, 2016. The Company’s Venezuelan operations represented less than 1% of the Company’s net assets, revenues and operating income for the three and nine months ended September 30, 2016.

The Company makes certain estimates and assumptions in preparing its Condensed Consolidated Financial Statements in accordance with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses for the periods presented. Actual results may differ from those estimates.

The results of operations for the three and nine months ended September 30, 2016 are not necessarily indicative of the results of operations that may be achieved for the full year. Quarterly results are affected by seasonal variations in the Company’s business. Historically, our gas- and fluid-handling shipments have peaked during the fourth quarter. Also, all of our European operations typically experience a slowdown during the July and August and December holiday seasons. General economic conditions may, however, impact future seasonal variations.

2. Recently Issued Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” (“ASU No. 2014-09”). ASU No. 2014-09 clarifies the principles for recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance affects entities that enter into contracts with customers to transfer goods or services, and supersedes prior GAAP guidance, namely Accounting Standards Codification Topic 605 — Revenue Recognition. ASU 2014-09 is to be applied on a full or modified retrospective basis. In August 2015, the FASB issued ASU No. 2015-14, “Revenue from Contracts with Customers (Topic 606) — Deferral of the Effective

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Date”, which delayed the effective date of ASU No. 2014-09 by one year. As a result, ASU No. 2014-09 will be effective for fiscal years beginning after December 15, 2017, with early adoption permitted but not prior to the original effective date of annual periods beginning after December 15, 2016. During the nine months ended September 30, 2016, the FASB issued three additional Accounting Standards Updates that clarify the original guidance as laid out in ASU No. 2014-09. These Accounting Standards Updates focus on clarification of principal versus agent considerations, performance obligations and licensing, and provides for application of certain practical expedients and narrow-scope improvements. The Company plans to apply these Accounting Standards Updates on a full retrospective basis as of January 1, 2018 and is currently evaluating the impact on its Consolidated Financial Statements.

In July 2015, the FASB issued ASU No. 2015-11, “Inventory (Topic 330) — Simplifying the Measurement of Inventory” (“ASU No. 2015-11”). ASU No. 2015-11 requires an entity to measure inventory at the lower of cost and net realizable value, except for inventory that is measured using the last-in, first-out method or the retail inventory method. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. ASU No. 2015-11 is effective for fiscal years beginning after December 15, 2016 and is to be applied prospectively with early adoption permitted. The Company is currently evaluating the impact of adopting ASU No. 2015-11 on its Consolidated Financial Statements.

In September 2015, the FASB issued ASU No. 2015-16, “Business Combinations (Topic 805) — Simplifying the Accounting for Measurement-Period Adjustments” (“ASU No. 2015-16”). ASU No. 2015-16 aims to simplify measurement period adjustments resulting from business combinations by requiring that an acquirer recognize adjustments to provisional amounts that are identified during the measurement period in the reporting period in which the adjustment amounts are determined. The effect on earnings of changes in depreciation, amortization, or other income effects, if any, as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date, will be recorded in the same period’s financial statements as the measurement period adjustment. ASU No. 2015-16 is effective for fiscal years beginning after December 15, 2015, and is to be applied prospectively to adjustments to provisional amounts that occur after the effective date of ASU No. 2015-16. The adoption of ASU No. 2015-16 during the nine months ended September 30, 2016 did not have a material impact on the Company’s Condensed Consolidated Financial Statements. See Note 3, “Acquisitions” for measurement period adjustments made during the nine months ended September 30, 2016, related to acquisitions that occurred during the year ended December 31, 2015.

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, “Leases (Topic 842)” (“ASU No. 2016-02”). ASU No. 2016-02 requires a lessee to recognize assets and liabilities associated with the rights and obligations attributable to most leases but also recognize expenses similar to current lease accounting. The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. Early adoption is permitted. The new guidance must be adopted using a modified retrospective transition and provides for certain practical expedients. The Company is currently evaluating the impact of adopting ASU No. 2016-02 on its Consolidated Financial Statements.

In March 2016, the FASB issued Accounting Standards Update No. 2016-09, “Compensation - Stock Compensation (Topic 718) — Improvements to Employee Share-Based Payment Accounting” (“ASU No. 2016-09”). ASU No. 2016-09 is effective for fiscal periods beginning after December 15, 2016 with early adoption permitted. ASU No. 2016-09 aims to simplify the accounting for shared-based payment accounting by recording all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement, eliminates the requirement that excess tax benefits be realized before they can be recognized, and provides the option to make an entity-wide accounting policy election to continue to estimate the amount of awards that are expected to vest or account for forfeitures as they occur. The effect for excess tax benefits not previously recognized will be recorded as a cumulative adjustment to retained earnings pursuant to a modified retrospective adoption method. Excess tax benefits and deficiencies will be accounted for as discrete items in the period the stock awards vest or otherwise are settled. Further, the guidance will require that excess tax benefits be presented as an operating activity on the statement of cash flows consistent with other income tax cash flows. ASU No. 2016-09 also increases share based withholding up to the maximum statutory tax rates in the applicable jurisdictions without causing the award to be classified as a liability. All provisions of ASU No. 2016-09 must be adopted in the same period. The Company plans to adopt ASU No. 2016-09 in the annual period beginning January 1, 2017. The Company is currently evaluating the impact of adopting ASU No. 2016-09 on its Consolidated Financial Statements.

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU No. 2016-13”). ASU No. 2016-13 is effective for fiscal periods beginning after December 15, 2019 with early adoption permitted. ASU No. 2016-13 eliminates the probable initial recognition threshold under current U.S. GAAP and broadens the information an entity must consider when developing its expected credit loss estimates to include forecast information that affects the collectibility of the reported amount. The Company is currently evaluating the impact of adopting ASU No. 2016-13 on its Consolidated Financial Statements.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

In August 2016, the FASB issued Accounting Standards Update No. 2016-15, “Statement of Cash Flows (Topic 203)” (“ASU No. 2016-15”). ASU No. 2016-15 is effective for fiscal years beginning after December 15, 2017 and is to be applied retrospectively with early adoption permitted. ASU No. 2016-15 addresses eight specific cash flow issues and clarifies their presentation and classification in the Statement of Cash Flows. The Company is currently evaluating the impact of adopting ASU No. 2016-15 on its Consolidated Financial Statements.

3. Acquisitions

The Company completed the acquisitions of the Roots^TM blowers and compressors business unit, also known as Industrial Air & Gas Technologies, from GE Oil & Gas (“Roots”) on June 30, 2015, and Simsmart Technologies, Inc. (“Simsmart”) on October 5, 2015. During the nine months ended September 30, 2016, the Company adjusted provisional amounts with respect to these acquisitions that were recognized at the acquisition date to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. The aggregate adjustments, primarily attributable to the Company’s valuation of inventory and revision of estimates based on additional information obtained for a specific environmental reserve, increased the Goodwill balance by $1.3 million during the nine months ended September 30, 2016.

The Company continues to evaluate the acquired assets and liabilities assumed for Simsmart during the measurement period as certain valuations and studies have yet to be finalized, and accordingly, the assets acquired and liabilities assumed are subject to adjustment once the detailed analyses are complete.

4. Net Income Per Share

Net income per share was computed as follows:



	Three Months Ended				Nine Months Ended
	September 30, 2016		September 25, 2015		September 30, 2016		September 25, 2015
	(In thousands, except share data)
Computation of Net income per share - basic:
Net income attributable to Colfax Corporation	$	27,970	$	18,359	$	90,339	$	123,542
Weighted-average shares of Common stock outstanding - basic	122,836,762		124,404,267		122,918,259		124,205,441
Net income per share - basic	$	0.23	$	0.15	$	0.73	$	0.99
Computation of Net income per share - diluted:
Net income attributable to Colfax Corporation	$	27,970	$	18,359	$	90,339	$	123,542
Weighted-average shares of Common stock outstanding - basic	122,836,762		124,404,267		122,918,259		124,205,441
Net effect of potentially dilutive securities - stock options and restricted stock units	265,452		628,000		211,540		928,165
Weighted-average shares of Common stock outstanding - diluted	123,102,214		125,032,267		123,129,799		125,133,606
Net income per share - diluted	$	0.23	$	0.15	$	0.73	$	0.99

The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the three months ended September 30, 2016 and September 25, 2015 excludes approximately 5.2 million and 3.2 million of outstanding stock-based compensation awards, respectively, as their inclusion would be anti-dilutive. The weighted-average computation of the dilutive effect of potentially issuable shares of Common stock under the treasury stock method for the nine months ended September 30, 2016 and September 25, 2015 excludes approximately 5.1 million and 2.5 million of outstanding stock-based compensation awards, respectively, as their inclusion would be anti-dilutive.

5. Income Taxes

During the three months ended September 30, 2016, Income before income taxes was $43.7 million, while the Provision for income taxes was $11.5 million, and the effective tax rate was 26.3%. During the nine months ended September 30, 2016, Income before income taxes was $147.4 million, while the Provision for income taxes was $45.1 million, and the effective tax rate was

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

30.6%. The effective tax rates differ from the U.S. federal statutory rate primarily due to international taxes, which are lower than the U.S. tax rate, offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2016.

During the three months ended September 25, 2015, Income before income taxes was $34.7 million, while the Provision for income taxes was $11.2 million and the effective tax rate was 32.1%. During the nine months ended September 25, 2015, Income before income taxes was $182.4 million, while the Provision for income taxes was $43.8 million, and the effective tax rate was 24.0%. The effective tax rates differ from the U.S. federal statutory rate primarily due to international tax rates, which are lower than the U.S. tax rate, offset in part by losses in certain jurisdictions where a tax benefit was not expected to be recognized in 2015. The Provision for income taxes for the nine months ended September 25, 2015 includes a tax benefit of $13.0 million associated with the resolution of certain liabilities for unrecognized tax benefits.

6. Equity

Share Repurchase Program

During the nine months ended September 30, 2016, the Company repurchased 1,000,000 shares of its Common stock in open market transactions for approximately $20.8 million under a plan complying with Rule 10b5-1 under the Securities Exchange Act of 1934. As of September 30, 2016, the remaining stock repurchase authorization provided by the Company’s Board of Directors is approximately $52 million.

Share-Based Payments

On May 13, 2016, the Company’s Board of Directors and stockholders approved the Colfax Corporation 2016 Omnibus Incentive Plan (the “2016 Plan”). Under the 2016 Plan, the Company has reserved up to 10.5 million shares of Common stock for potential issuance as stock-based compensation. Upon approval of the 2016 Plan, awards are no longer granted under the previously existing Colfax Corporation Omnibus Incentive Plan, as amended and restated on April 2, 2012.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Accumulated Other Comprehensive Loss

The following tables present the changes in the balances of each component of Accumulated other comprehensive loss including reclassifications out of Accumulated other comprehensive loss for the nine months ended September 30, 2016 and September 25, 2015. All amounts are net of tax and noncontrolling interest.



	Accumulated Other Comprehensive Loss Components
	Net Unrecognized Pension And Other Post-Retirement Benefit Cost			Foreign Currency Translation Adjustment			Unrealized Gain On Hedging Activities		Total
	(In thousands)
Balance at January 1, 2016	$	(193,258	)	$	(528,620	)	$	35,163	$	(686,715	)
Other comprehensive income (loss) before reclassifications:
Foreign currency translation adjustment	370			(161,436		)	758		(160,308		)
Loss on long-term intra-entity foreign currency transactions	—			(30,353		)	—		(30,353		)
Gain on net investment hedges	—			—			3,482		3,482
Unrealized gain on cash flow hedges	—			—			327		327
Other comprehensive income (loss) before reclassifications	370			(191,789		)	4,567		(186,852		)
Amounts reclassified from Accumulated other comprehensive loss	3,579			2,378			—		5,957
Net current period Other comprehensive income (loss)	3,949			(189,411		)	4,567		(180,895		)
Balance at September 30, 2016	$	(189,309	)	$	(718,031	)	$	39,730	$	(867,610	)



	Accumulated Other Comprehensive Loss Components
	Net Unrecognized Pension And Other Post-Retirement Benefit Cost			Foreign Currency Translation Adjustment			Unrealized Gain On Hedging Activities			Total
	(In thousands)
Balance at January 1, 2015	$	(240,513	)	$	(227,059	)	$	23,881		$	(443,691	)
Other comprehensive income (loss) before reclassifications:
Foreign currency translation adjustment	6,090			(198,347		)	(365		)	(192,622		)
Loss on long-term intra-entity foreign currency transactions	—			(8,203		)	—			(8,203		)
Gain on net investment hedges	—			—			8,727			8,727
Unrealized loss on cash flow hedges	—			—			(3,350		)	(3,350		)
Other	3,817			—			—			3,817
Other comprehensive income (loss) before reclassifications	9,907			(206,550		)	5,012			(191,631		)
Amounts reclassified from Accumulated other comprehensive loss	5,887			—			—			5,887
Net current period Other comprehensive income (loss)	15,794			(206,550		)	5,012			(185,744		)
Balance at September 25, 2015	$	(224,719	)	$	(433,609	)	$	28,893		$	(629,435	)

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The effect on Net income of amounts reclassified out of each component of Accumulated other comprehensive loss for the three and nine months ended September 30, 2016 and September 25, 2015 is as follows:



	Three Months Ended September 30, 2016							Nine Months Ended September 30, 2016
	Amounts Reclassified From Accumulated Other Comprehensive Loss		Tax (Benefit) Expense			Total		Amounts Reclassified From Accumulated Other Comprehensive Loss		Tax (Benefit) Expense			Total
	(In thousands)

Pension and other post-retirement benefit cost:
Amortization of net loss⁽¹⁾	$	1,285	$	(736	)	$	549	$	5,367	$	(2,186	)	$	3,181
Amortization of prior service cost⁽¹⁾	62		260			322		186		212			398
Other:
Foreign currency translation adjustment⁽²⁾	2,378		—			2,378		2,378		—			2,378
	$	3,725	$	(476	)	$	3,249	$	7,931	$	(1,974	)	$	5,957



	Three Months Ended September 25, 2015							Nine Months Ended September 25, 2015
	Amounts Reclassified From Accumulated Other Comprehensive Loss		Tax Benefit			Total		Amounts Reclassified From Accumulated Other Comprehensive Loss		Tax Benefit			Total
	(In thousands)

Pension and other post-retirement benefit cost:
Amortization of net loss⁽¹⁾	$	2,662	$	(903	)	$	1,759	$	9,276	$	(3,574	)	$	5,702
Amortization of prior service cost⁽¹⁾	54		—			54		185		—			185
	$	2,716	$	(903	)	$	1,813	$	9,461	$	(3,574	)	$	5,887

⁽¹⁾Included in the computation of net periodic benefit (income) cost. See Note 10, “Net Periodic Benefit Cost - Defined Benefit Plans” for additional details.

⁽²⁾ Represents foreign currency translation charges reclassified as a result of the deconsolidation of the Company’s Venezuelan operations which are included in Selling, general and administrative expense for the three and nine months ended September 30, 2016. See Note 1, “General” for additional details.

During the nine months ended September 30, 2016, Noncontrolling interest increased by $4.9 million as a result of Other comprehensive income, primarily due to foreign currency translation adjustment. During the nine months ended September 25, 2015, Noncontrolling interest decreased by $16.5 million as a result of Other comprehensive loss, primarily due to foreign currency translation adjustment.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)

(Unaudited)

7. Inventories, Net

Inventories, net consisted of the following:



	September 30, 2016			December 31, 2015
	(In thousands)
Raw materials	$	147,560		$	160,640
Work in process	89,354			68,541
Finished goods	253,750			243,209
	490,664			472,390
Less: customer progress payments	(17,234		)	(15,876		)
Less: allowance for excess, slow-moving and obsolete inventory	(49,525		)	(36,128		)
Inventories, net	$	423,905		$	420,386

8. Debt

Long-term debt consisted of the following:



	September 30, 2016			December 31, 2015
	(In thousands)
Term loans	$	687,012		$	713,175
Trade receivables financing arrangement	76,643			75,800
Revolving credit facilities and other	621,485			628,572
Total Debt	1,385,140			1,417,547
Less: current portion	(6,082		)	(5,792		)
Long-term debt	$	1,379,058		$	1,411,755

The Company is party to a credit agreement by and among the Company, as the borrower, certain U.S. subsidiaries of the Company identified therein, as guarantors, each of the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent, swing line lender and global coordinator (the “Credit Agreement”).

The Company had an original issue discount of $6.0 million and deferred financing fees of $6.5 million included in its Condensed Consolidated Balance Sheet as of September 30, 2016, which will be accreted to Interest expense, primarily using the effective interest method, over the life of the Credit Agreement. As of September 30, 2016, the weighted-average interest rate of borrowings under the Credit Agreement was 1.92%, excluding accretion of original issue discount and deferred financing fees, and there was $779.4 million available on the revolving credit facility.

The Company is also party to letter of credit facilities with total capacity of $756.8 million. Total letters of credit of $352.5 million were outstanding as of September 30, 2016.

The Company is party to a receivables financing facility through a wholly-owned, special purpose bankruptcy-remote subsidiary which purchases trade receivables from certain of the Company’s subsidiaries on an ongoing basis and pledges them to support its obligation as borrower under the receivables financing facility. This special purpose subsidiary has a separate legal existence from its parent and its assets are not available to satisfy the claims of creditors of the selling subsidiaries or any other member of the consolidated group. Availability of funds may fluctuate over time given changes in eligible receivable balances, but will not exceed the program limit. On August 16, 2016, the receivables financing facility program limit decreased by $15 million from $95 million to $80 million. As of September 30, 2016, the total outstanding borrowings under the receivables financing facility were $76.6 million and the interest rate was 1.39%. The scheduled termination date for the receivables financing facility is December 20, 2016 and may be extended from time to time.

As of September 30, 2016, the Company is in compliance with the covenants under the Credit Agreement.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

9. Accrued Liabilities

Accrued liabilities in the Condensed Consolidated Balance Sheets consisted of the following:



	September 30, 2016		December 31, 2015
	(In thousands)
Accrued payroll	$	108,511	$	99,383
Advance payment from customers	52,921		45,590
Accrued taxes	44,504		51,834
Accrued asbestos-related liability	53,181		48,780
Warranty liability - current portion	34,923		36,128
Accrued restructuring liability - current portion	14,703		12,918
Accrued third-party commissions	9,455		10,275
Other	98,775		86,751
Accrued liabilities	$	416,973	$	391,659

Warranty Liability

The activity in the Company’s warranty liability consisted of the following:



	Nine Months Ended
	September 30, 2016			September 25, 2015
	(In thousands)
Warranty liability, beginning of period	$	37,407		$	51,135
Accrued warranty expense	16,339			14,392
Changes in estimates related to pre-existing warranties	3,231			(2,467		)
Cost of warranty service work performed	(21,681		)	(18,657		)
Acquisitions	—			321
Foreign exchange translation effect	918			(3,142		)
Warranty liability, end of period	$	36,214		$	41,582

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Accrued Restructuring Liability

The Company’s restructuring programs include a series of restructuring actions to reduce the structural costs of the Company.

A summary of the activity in the Company’s restructuring liability included in Accrued liabilities and Other liabilities in the Condensed Consolidated Balance Sheets is as follows:



	Nine Months Ended September 30, 2016
	Balance at Beginning of Period		Provisions		Payments			Foreign Currency Translation			Balance at End of Period⁽³⁾
	(In thousands)
Restructuring and other related charges:
Gas and Fluid Handling:
Termination benefits⁽¹⁾	$	3,979	$	18,882	$	(14,275	)	$	(10	)	$	8,576
Facility closure costs⁽²⁾	2,657		6,946		(9,190		)	74			487
	6,636		25,828		(23,465		)	64			9,063
Non-cash charges			2,124
			27,952
Fabrication Technology:
Termination benefits⁽¹⁾	6,031		15,893		(17,495		)	(54		)	4,375
Facility closure costs⁽²⁾	426		4,149		(3,234		)	(39		)	1,302
	6,457		20,042		(20,729		)	(93		)	5,677
Non-cash charges			1,323
			21,365
Corporate and Other:
Facility closure costs⁽²⁾	625		—		(202		)	(61		)	362
	625		—		(202		)	(61		)	362
	$	13,718	45,870		$	(44,396	)	$	(90	)	$	15,102
Non-cash charges			3,447
			$	49,317

⁽¹⁾Includes severance and other termination benefits, including outplacement services. The Company recognizes the cost of involuntary termination benefits at the communication date or ratably over any remaining expected future service period. Voluntary termination benefits are recognized as a liability and an expense when employees accept the offer and the amount can be reasonably estimated.

⁽²⁾Includes the cost of relocating associates, relocating equipment and lease termination expense in connection with the closure of facilities.

⁽³⁾As of September 30, 2016, $14.7 million and $0.4 million of the Company’s restructuring liability was included in Accrued liabilities and Other liabilities, respectively.

The Company expects to incur charges of approximately $20 million during the remainder of 2016 related to its restructuring activities.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

10. Net Periodic Benefit Cost - Defined Benefit Plans

The following table sets forth the components of net periodic benefit (income) cost of the Company’s defined benefit pension plans and other post-retirement employee benefit plans:



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(In thousands)
Pension Benefits-U.S. Plans:
Service cost	$	48		$	—		$	144		$	—
Interest cost	4,352			4,128			13,057			12,709
Expected return on plan assets	(6,121		)	(6,150		)	(18,362		)	(18,189		)
Amortization	1,612			1,665			4,846			5,464
Net periodic benefit income	$	(109	)	$	(357	)	$	(315	)	$	(16	)

Pension Benefits-Non U.S. Plans:
Service cost	$	821		$	947		$	2,512		$	2,972
Interest cost	7,287			9,563			24,447			29,099
Expected return on plan assets	(6,604		)	(8,485		)	(22,804		)	(26,294		)
Amortization	417			907			1,261			3,486
Net periodic benefit cost	$	1,921		$	2,932		$	5,416		$	9,263

Other Post-Retirement Benefits:
Service cost	$	(2	)	$	49		$	29		$	151
Interest cost	154			248			779			887
Amortization	(682		)	144			(554		)	511
Net periodic benefit (income) cost	$	(530	)	$	441		$	254		$	1,549

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

11. Financial Instruments and Fair Value Measurements

The carrying values of financial instruments, including Trade receivables and Accounts payable, approximate their fair values due to their short-term maturities. The estimated fair value of the Company’s debt of $1.4 billion as of both September 30, 2016 and December 31, 2015 was based on current interest rates for similar types of borrowings and is in Level Two of the fair value hierarchy. The estimated fair values may not represent actual values of the financial instruments that could be realized as of the balance sheet date or that will be realized in the future.

A summary of the Company’s assets and liabilities that are measured at fair value for each fair value hierarchy level for the periods presented is as follows:



	September 30, 2016
	Level One		Level Two		Level Three		Total
	(In thousands)
Assets:
Cash equivalents	$	19,604	$	—	$	—	$	19,604
Foreign currency contracts related to sales - designated as hedges	—		1,322		—		1,322
Foreign currency contracts related to sales - not designated as hedges	—		496		—		496
Foreign currency contracts related to purchases - designated as hedges	—		4,031		—		4,031
Foreign currency contracts related to purchases - not designated as hedges	—		50		—		50
Deferred compensation plans	—		4,416		—		4,416
	$	19,604	$	10,315	$	—	$	29,919

Liabilities:
Foreign currency contracts related to sales - designated as hedges	$	—	$	8,805	$	—	$	8,805
Foreign currency contracts related to sales - not designated as hedges	—		259		—		259
Foreign currency contracts related to purchases - designated as hedges	—		519		—		519
Foreign currency contracts related to purchases - not designated as hedges	—		398		—		398
Deferred compensation plans	—		4,416		—		4,416
	$	—	$	14,397	$	—	$	14,397



	December 31, 2015
	Level One		Level Two		Level Three		Total
	(In thousands)
Assets:
Cash equivalents	$	22,516	$	—	$	—	$	22,516
Foreign currency contracts related to sales - designated as hedges	—		988		—		988
Foreign currency contracts related to sales - not designated as hedges	—		664		—		664
Foreign currency contracts related to purchases - designated as hedges	—		1,554		—		1,554
Foreign currency contracts related to purchases - not designated as hedges	—		338		—		338
Deferred compensation plans	—		4,000		—		4,000
	$	22,516	$	7,544	$	—	$	30,060

Liabilities:
Foreign currency contracts related to sales - designated as hedges	$	—	$	6,368	$	—	$	6,368
Foreign currency contracts related to sales - not designated as hedges	—		969		—		969
Foreign currency contracts related to purchases - designated as hedges	—		322		—		322
Foreign currency contracts related to purchases - not designated as hedges	—		128		—		128
Deferred compensation plans	—		4,000		—		4,000
	$	—	$	11,787	$	—	$	11,787

There were no transfers in or out of Level One, Two or Three during the nine months ended September 30, 2016.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

Foreign Currency Contracts

As of September 30, 2016 and December 31, 2015, the Company had foreign currency contracts with the following notional values:



	September 30, 2016		December 31, 2015
	(In thousands)
Foreign currency contracts sold - not designated as hedges	$	73,676	$	119,653
Foreign currency contracts sold - designated as hedges	203,814		206,366
Foreign currency contracts purchased - not designated as hedges	36,124		41,480
Foreign currency contracts purchased - designated as hedges	70,400		62,794
Total foreign currency derivatives	$	384,014	$	430,293

The Company recognized the following in its Condensed Consolidated Financial Statements related to its derivative instruments:



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(In thousands)
Contracts Designated as Hedges:
Foreign Currency Contracts - related to customer sales contracts:
Unrealized (loss) gain	$	(362	)	$	(4,354	)	$	496		$	(3,846	)
Realized gain (loss)	297			(2,378		)	(2,075		)	1,124
Foreign Currency Contracts - related to supplier purchase contracts:
Unrealized gain (loss)	403			(666		)	(838		)	(990		)
Realized (loss) gain	(207		)	2,072			2,504			122
Unrealized gain (loss) on net investment hedges⁽¹⁾	9,187			(1,485		)	3,482			8,727
Contracts Not Designated in a Hedge Relationship:
Foreign Currency Contracts - related to customer sales contracts:
Unrealized gain	94			774			541			3,046
Realized loss	(579		)	(449		)	(670		)	(4,710		)
Foreign Currency Contracts - related to supplier purchases contracts:
Unrealized (loss) gain	(42		)	(342		)	(558		)	45
Realized loss	(360		)	(548		)	(621		)	(134		)

⁽¹⁾The unrealized gain (loss) on net investment hedges is attributable to the change in valuation of Euro denominated debt.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

12. Commitments and Contingencies

For further description of the Company’s litigation and contingencies, reference is made to Note 15, “Commitments and Contingencies” in the Notes to Consolidated Financial Statements in our 2015 Form 10-K.

Asbestos and Other Product Liability Contingencies

Claims activity since December 31 related to asbestos claims is as follows⁽¹⁾:



	Nine Months Ended
	September 30, 2016		September 25, 2015
	(Number of claims)
Claims unresolved, beginning of period	20,583		21,681
Claims filed⁽²⁾	4,022		3,711
Claims resolved⁽³⁾	(3,092	)	(3,260	)
Claims unresolved, end of period	21,513		22,132

⁽¹⁾Excludes claims filed by one legal firm that have been “administratively dismissed.”

⁽²⁾Claims filed include all asbestos claims for which notification has been received or a file has been opened.

⁽³⁾Claims resolved include all asbestos claims that have been settled, dismissed or that are in the process of being settled or dismissed based upon agreements or understandings in place with counsel for the claimants.

The Company’s Condensed Consolidated Balance Sheets included the following amounts related to asbestos-related litigation:



	September 30, 2016		December 31, 2015
	(In thousands)
Current asbestos insurance asset⁽¹⁾	$	27,259	$	28,872
Long-term asbestos insurance asset⁽²⁾	274,106		284,095
Long-term asbestos insurance receivable⁽²⁾	110,254		96,007
Accrued asbestos liability⁽³⁾	53,181		48,780
Long-term asbestos liability⁽⁴⁾	339,514		350,394

⁽¹⁾Included in Other current assets in the Condensed Consolidated Balance Sheets.

⁽²⁾Included in Other assets in the Condensed Consolidated Balance Sheets.

⁽³⁾Represents the current portion of reserves for probable and reasonably estimable asbestos-related liability cost that the Company believes its subsidiaries will pay through the next 15 years, overpayments by certain insurers and unpaid legal costs related to defending themselves against asbestos-related liability claims and legal action against the Company’s insurers, which is included in Accrued liabilities in the Condensed Consolidated Balance Sheets.

⁽⁴⁾Included in Other liabilities in the Condensed Consolidated Balance Sheets.

On September 12, 2016, the Delaware Supreme Court, after receiving responses from the New York Court of Appeals on questions certified to it, affirmed prior rulings that an “all sums” allocation applies to the subsidiary’s insurance policies and that the subsidiary has rights under the excess insurance policies issued to a former owner of the business. The Court also ruled on other matters including specific determinations of coverage for defense costs under the excess policies. The net result of the ruling is an adjustment to the Company’s expected future recoveries, resulting in an $8.2 million reduction to the net recoverable insurance asset recorded as a charge to the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2016. The estimated future expected recovery rate may change over time as these claims are fully settled, which may result in periodic adjustments impacting our financial condition and results of operations.

Certain matters, including potential interest which could be awarded to the subsidiary, are subject to further rulings from the Delaware courts. While the outcome is uncertain, none of these matters is expected to have a material adverse effect on the financial condition, results of operations or cash flows of the Company.

The Delaware Supreme Court’s ruling is also expected to result in the receipt from excess insurers of approximately $88 million in unreimbursed costs funded by the subsidiary in defense and settlement of asbestos claims, although the timing of cash

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

receipts remains uncertain. It also is expected to reduce significantly the extent to which the Company is required to fund future defense and settlement costs, compared to levels experienced prior to the ruling.

The estimated asbestos-related liabilities of the other subsidiary have been increased $8.0 million due to higher estimated settlement values per claim, and the related insurance asset has been increased $6.1 million, resulting in a net charge to Selling, general and administrative expense of $1.9 million for three and nine months ended September 30, 2016.

Management’s analyses are based on currently known facts and a number of assumptions. However, projecting future events, such as new claims to be filed each year, the average cost of resolving each claim, coverage issues among layers of insurers, the method in which losses will be allocated to the various insurance policies, interpretation of the effect on coverage of various policy terms and limits and their interrelationships, the continuing solvency of various insurance companies, the amount of remaining insurance available, as well as the numerous uncertainties inherent in asbestos litigation could cause the actual liabilities and insurance recoveries to be higher or lower than those projected or recorded which could materially affect the Company’s financial condition, results of operations or cash flow.

Other Litigation Matters

The Lincoln Electric Company and Lincoln Global, Inc. (collectively, “Lincoln Electric”) filed suit against The ESAB Group, Inc. and ESAB AB in the United States District Court, Eastern District of Texas, alleging infringement of certain patents allegedly owned by Lincoln Electric. The complaint, as amended, seeks undisclosed damages plus interest, an award of attorneys’ fees and expenses, and injunctive relief. The defendants answered the complaint, denying Lincoln Electric’s infringement allegations and asserting affirmative defenses, on October 20, 2015. The litigation is not expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. The defendants are vigorously defending against the claims.

The Company is also involved in various other pending legal proceedings arising out of the ordinary course of the Company’s business. None of these legal proceedings are expected to have a material adverse effect on the financial condition, results of operations or cash flow of the Company. With respect to these proceedings and the litigation and claims described in the preceding paragraphs, management of the Company believes that it will either prevail, has adequate insurance coverage or has established appropriate accruals to cover potential liabilities. Any costs that management estimates may be paid related to these proceedings or claims are accrued when the liability is considered probable and the amount can be reasonably estimated. There can be no assurance, however, as to the ultimate outcome of any of these matters, and if all or substantially all of these legal proceedings were to be determined adverse to the Company, there could be a material adverse effect on the financial condition, results of operations or cash flow of the Company.

13. Segment Information

The Company conducts its operations through three operating segments: gas handling, fluid handling and fabrication technology. The gas-handling and fluid-handling operating segments are aggregated into a single reportable segment. A description of the Company’s reportable segments is as follows:

▪

Gas and Fluid Handling - a global supplier of a broad range of gas- and fluid-handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps, fluid-handling systems, controls and specialty valves, which serves customers in the power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other end markets; and


▪	Fabrication Technology - a global supplier of welding equipment and consumables, cutting equipment and consumables and automated welding and cutting systems.

Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.” The Company’s management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income (loss), which represents Operating income (loss) before Restructuring and other related charges.

COLFAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS — (Continued)

(Unaudited)

The Company’s segment results were as follows:



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(In thousands)
Net sales:
Gas and fluid handling	$	433,119		$	481,908		$	1,349,549		$	1,408,992
Fabrication technology	446,085			487,236			1,363,747			1,496,597
	$	879,204		$	969,144		$	2,713,296		$	2,905,589
Segment operating income (loss)⁽¹⁾:
Gas and fluid handling	$	29,246		$	26,634		$	108,262		$	127,097
Fabrication technology	48,074			42,415			148,430			153,635
Corporate and other	(9,641		)	(10,423		)	(35,327		)	(35,492		)
	$	67,679		$	58,626		$	221,365		$	245,240

⁽¹⁾The following is a reconciliation of Income before income taxes to segment operating income:



	Three Months Ended				Nine Months Ended
	September 30, 2016		September 25, 2015		September 30, 2016		September 25, 2015
	(In thousands)
Income before income taxes	$	43,728	$	34,698	$	147,425	$	182,432
Interest expense	6,792		10,857		24,623		37,150
Restructuring and other related charges	17,159		13,071		49,317		25,658
Segment operating income	$	67,679	$	58,626	$	221,365	$	245,240

The detail of the Company’s Net sales by product type is as follows:



	Three Months Ended				Nine Months Ended
	September 30, 2016		September 25, 2015		September 30, 2016		September 25, 2015
	(In thousands)
Gas handling	$	320,437	$	353,562	$	1,009,599	$	1,019,587
Fluid handling	112,682		128,345		339,950		389,404
Welding and cutting	446,085		487,237		1,363,747		1,496,598
Total Net sales	$	879,204	$	969,144	$	2,713,296	$	2,905,589

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the financial condition and results of operations of Colfax Corporation (“Colfax,” “the Company,” “we,” “our,” and “us”) should be read in conjunction with the Condensed Consolidated Financial Statements and related footnotes included in Part I. Item 1. “Financial Statements” of this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2016 (this “Form 10-Q”) and the Consolidated Financial Statements and related footnotes included in Part II. Item 8. “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended December 31, 2015 (the “2015 Form 10-K”) filed with the Securities and Exchange Commission (the “SEC”) on February 16, 2016.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Some of the statements contained in this Form 10-Q that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date this Form 10-Q is filed with the SEC. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including statements regarding: projections of revenue, profit margins, expenses, tax provisions and tax rates, earnings or losses from operations, impact of foreign exchange rates, cash flows, pension and benefit obligations and funding requirements, synergies or other financial items; plans, strategies and objectives of management for future operations including statements relating to potential acquisitions, compensation plans or purchase commitments; developments, performance or industry or market rankings relating to products or services; future economic conditions or performance; the outcome of outstanding claims or legal proceedings including asbestos-related liabilities and insurance coverage litigation; potential gains and recoveries of costs; assumptions underlying any of the foregoing; and any other statements that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. Forward-looking statements may be characterized by terminology such as “believe,” “anticipate,” “should,” “would,” “intend,” “plan,” “will,” “expect,” “estimate,” “project,” “positioned,” “strategy,” “targets,” “aims,” “seeks,” “sees,” and similar expressions. These statements are based on assumptions and assessments made by our management in light of their experience and perception of historical trends, current conditions, expected future developments and other factors we believe to be appropriate. These forward-looking statements are subject to a number of risks and uncertainties, including but not limited to the following:


•	changes in the general economy, as well as the cyclical nature of the markets we serve;


•	a significant or sustained decline in commodity prices, including oil;


•	our ability to identify, finance, acquire and successfully integrate attractive acquisition targets;


•	our exposure to unanticipated liabilities resulting from acquisitions;


•	our ability and the ability of our customers to access required capital at a reasonable cost;


•	our ability to accurately estimate the cost of or realize savings from our restructuring programs;


•	the amount of and our ability to estimate our asbestos-related liabilities;


•	the solvency of our insurers and the likelihood of their payment for asbestos-related costs;


•	material disruptions at any of our manufacturing facilities;


•	noncompliance with various laws and regulations associated with our international operations, including anti-bribery laws, export control regulations and sanctions and embargoes;


•	risks associated with our international operations;


•	risks associated with the representation of our employees by trade unions and work councils;


•	our exposure to product liability claims;


•	potential costs and liabilities associated with environmental, health and safety laws and regulations;


•	failure to maintain, protect and defend our intellectual property rights;


•	the loss of key members of our leadership team;

•

restrictions in our credit agreement entered into on June 5, 2015 by and among the Company, as the borrower, certain U.S. subsidiaries of the Company identified therein, as guarantors, each of the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent, swing line lender and global coordinator (the “Credit Agreement”) that may limit our flexibility in operating our business;


•	impairment in the value of intangible assets;


•	the funding requirements or obligations of our defined benefit pension plans and other post-retirement benefit plans;


•	significant movements in foreign currency exchange rates;


•	availability and cost of raw materials, parts and components used in our products;


•	new regulations and customer preferences reflecting an increased focus on environmental, social and governance issues, including new regulations related to the use of conflict minerals;


•	service interruptions, data corruption, cyber-based attacks or network security breaches affecting our information technology infrastructure;


•	risks arising from changes in technology;


•	the competitive environment in our industry;


•	changes in our tax rates or exposure to additional income tax liabilities;


•	our ability to manage and grow our business and execution of our business and growth strategies;


•	the level of capital investment and expenditures by our customers in our strategic markets;


•	our financial performance; and


•	other risks and factors, listed in Item 1A. “Risk Factors” in Part I of our 2015 Form 10-K.

Any such forward-looking statements are not guarantees of future performance and actual results, developments and business decisions may differ materially from those envisaged by such forward-looking statements. These forward-looking statements speak only as of the date this Form 10-Q is filed with the SEC. We do not assume any obligation and do not intend to update any forward-looking statement except as required by law. See Part I. Item 1A. “Risk Factors” in our 2015 Form 10-K for a further discussion regarding some of the reasons that actual results may be materially different from those that we anticipate.

Overview

We report our operations through the following reportable segments:

•

Gas and Fluid Handling - a global supplier of a broad range of gas- and fluid-handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps, fluid-handling systems and controls and specialty valves, which serves customers in the power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other end markets; and


•	Fabrication Technology - a global supplier of welding equipment and consumables, cutting equipment and consumables and automated welding and cutting systems.

Certain amounts not allocated to the two reportable segments and intersegment eliminations are reported under the heading “Corporate and other.”

Colfax has a global geographic footprint, with production facilities in Europe, North America, South America, Asia, Australia and Africa. Through our reportable segments, we serve a global customer base across multiple markets through a combination of direct sales and third-party distribution channels. Our customer base is highly diversified and includes commercial, industrial and government customers.

We employ a comprehensive set of tools that we refer to as the Colfax Business System (“CBS”). CBS is our business management system. It is a repeatable, teachable process that we use to create superior value for our customers, shareholders and associates. Rooted in our core values, it is our culture. CBS provides the tools and techniques to ensure that we are continuously improving our ability to meet or exceed customer requirements on a consistent basis.

Results of Operations

The following discussion of Results of Operations addresses the comparison of the periods presented. Our management evaluates the operating results of each of its reportable segments based upon Net sales and segment operating income (loss), which represents Operating income before Restructuring and other related charges.

Items Affecting Comparability of Reported Results

The comparability of our operating results for the third quarter and nine months ended September 30, 2016 to the comparable 2015 period is affected by the following additional significant items:

Strategic Acquisitions

We complement our organic growth plans with strategic acquisitions. Acquisitions can significantly affect our reported results and can complicate period to period comparisons of results. As a consequence, we report the change in our Net sales between periods both from existing and acquired businesses. Orders and order backlog are presented only for the gas- and fluid-handling segment, where this information is relevant. The change in Net sales due to acquisitions represents the change in sales due to the following acquisitions:

Gas and Fluid Handling

On June 30, 2015, Colfax completed the acquisition of the Roots^TM blowers and compressors business unit, also known as Industrial Air & Gas Technologies, from GE Oil & Gas (the “Roots Acquisition”) for cash consideration of $180.7 million, inclusive of a purchase price settlement in the fourth quarter of 2015. The acquisition builds on Howden’s global strength in compressors and blowers and adds important application expertise and product solutions to the portfolio.

On October 5, 2015, Colfax completed the acquisition of Simsmart Technologies, Inc. for cash consideration of $15.3 million, net of cash acquired. Simsmart provides software and services to control ventilation conditions and increase fan efficiency. The acquisition of Simsmart expands the Howden product portfolio for mining and other challenging ventilation conditions.

Foreign Currency Fluctuations

A significant portion of our Net sales, approximately 75% and 72% for the third quarter and nine months ended September 30, 2016, respectively, is derived from operations outside the U.S., with the majority of those sales denominated in currencies other than the U.S. dollar. Because much of our manufacturing and employee costs are outside the U.S., a significant portion of our costs are also denominated in currencies other than the U.S. dollar. Changes in foreign exchange rates can impact our results of operations and are quantified when significant to our discussion. Changes in foreign exchange rates have reduced Net sales by approximately 3% and 4% for the third quarter and nine months ended September 30, 2016, respectively. For the third quarter and nine months ended September 30, 2016, changes in foreign exchange rates also reduced Income before income taxes by approximately 7% and 6%, respectively. The changes in foreign exchange rates since December 31, 2015 decreased net assets by approximately 5%, due primarily to significant intangible assets denominated in British pounds.

During the third quarter of 2016, we determined that an other-than-temporary lack of exchangeability between the Venezuelan bolivar and U.S. dollar, due to government controls, restricted our Venezuelan operations ability to pay dividends and satisfy other obligations denominated in U.S. dollars. In addition, other government-imposed restrictions affecting labor, production, and distribution are prohibiting the Company from controlling key operating decisions. These circumstances have caused the Company to no longer meet the accounting criteria of control in order to continue consolidating its Venezuelan operations. Therefore, we have deconsolidated the financial statements of our Venezuelan operations as of September 30, 2016. As a result of the deconsolidation, we recorded a charge of $2.4 million in Selling, general and administrative expense for the third quarter and nine months ended September 30, 2016, substantially all of which related to accumulated foreign currency translation charges previously included in Accumulated other comprehensive loss. Due to loss of control, we have applied the cost method of accounting for our Venezuelan operations as of September 30, 2016. Our Venezuelan operations represented less than 1% of our net assets, revenues and operating income for the third quarter and nine months ended September 30, 2016.

Seasonality

Historically, our gas- and fluid-handling shipments have peaked during the fourth quarter. Also, all of our European operations typically experience a slowdown during the July and August and December holiday seasons. General economic conditions may, however, impact future seasonal variations.

Sales, Orders and Backlog

Our Net sales decreased from $969.1 million in the third quarter of 2015 to $879.2 million in the third quarter of 2016. Our Net sales decreased from $2,905.6 million in the nine months ended September 25, 2015 to $2,713.3 million in the nine months ended September 30, 2016. The following tables present the components of changes in our consolidated Net sales and, for our gas- and fluid-handling segment, orders and order backlog:



	Net Sales					Orders⁽¹⁾
	$			%		$			%
	(In millions)
For the three months ended September 25, 2015	$	969.1				$	444.2
Components of Change:
Existing businesses⁽²⁾	(65.9		)	(6.8	)%	37.8			8.5	%
Acquisitions⁽³⁾	1.3			0.1	%	4.8			1.1	%
Foreign currency translation⁽⁴⁾	(25.3		)	(2.6	)%	(10.0		)	(2.3	)%
	(89.9		)	(9.3	)%	32.6			7.3	%
For the three months ended September 30, 2016	$	879.2				$	476.8



	Net Sales					Orders⁽¹⁾					Backlog at Period End
	$			%		$			%		$			%
	(In millions)
As of and for the nine months ended September 25, 2015	$	2,905.6				$	1,393.4				$	1,313.8
Components of Change:
Existing businesses⁽²⁾	(125.6		)	(4.3	)%	(81.7		)	(5.9	)%	(188.0		)	(14.3	)%
Acquisitions⁽³⁾	51.6			1.8	%	66.6			4.8	%	3.5			0.3	%
Foreign currency translation⁽⁴⁾	(118.3		)	(4.1	)%	(48.1		)	(3.4	)%	(21.3		)	(1.7	)%
	(192.3		)	(6.6	)%	(63.2		)	(4.5	)%	(205.8		)	(15.7	)%
As of and for the nine months ended September 30, 2016	$	2,713.3				$	1,330.2				$	1,108.0

⁽¹⁾Represents contracts for products or services, net of cancellations for the period, for our gas- and fluid-handling segment.

⁽²⁾Excludes the impact of foreign exchange rate fluctuations and acquisitions, thus providing a measure of growth due to factors such as price, product mix and volume; backlog includes cancellations of orders from prior years.

⁽³⁾Represents the incremental sales, orders and order backlog as a result of our acquisitions.

⁽⁴⁾Represents the difference between prior year sales, orders and order backlog valued at the actual prior year foreign exchange rates and prior year sales, orders and order backlog valued at current year foreign exchange rates.

The decrease in Net sales from existing businesses during the third quarter of 2016 compared to the third quarter of 2015 was attributable to decreases of $37.4 million in our gas- and fluid-handling segment and $28.5 million in our fabrication technology segment. Orders, net of cancellations, from existing businesses for our gas- and fluid-handling segment increased during the third quarter of 2016 compared to the third quarter of 2015 due to increases in the oil, gas, and petrochemical and mining end markets, partially offset by declines in the power generation, marine and general industrial and other industrial end markets.

The decrease in Net sales from existing businesses during the nine months ended September 30, 2016 compared to the nine months ended September 25, 2015 was attributable to decreases of $59.8 million in our fabrication technology segment and $65.8 million in our gas- and fluid-handling segment. Orders, net of cancellations, from existing businesses for our gas- and fluid-handling segment decreased during the nine months ended September 30, 2016 compared to the nine months ended September 25, 2015 due to declines in the power generation, oil, gas, and petrochemical, marine and general industrial and other end markets, partially offset by an increase in the mining end market.

Business Segments

As discussed further above, we report results in two reportable segments: gas and fluid handling and fabrication technology.

Gas and Fluid Handling

We design, manufacture, install and maintain gas- and fluid-handling products for use in a wide range of markets, including power generation, oil, gas and petrochemical, mining, marine (including defense) and general industrial and other. Our gas-handling products are principally marketed under the Howden brand name. Howden’s primary products are heavy-duty fans, rotary heat exchangers and compressors. The fans and heat exchangers are used in coal-fired and other types of power stations, both in combustion and emissions control applications, underground mines, steel sintering plants and other industrial facilities that require movement of large volumes of air in harsh applications. Howden’s compressors are mainly used in the oil, gas and petrochemical end market. Our fluid-handling products are marketed by Colfax Fluid Handling under a portfolio of brands including Allweiler and Imo. Colfax Fluid Handling is a supplier of a broad range of fluid-handling products, including pumps, fluid-handling systems and controls, and specialty valves.

The following table summarizes selected financial data for our gas- and fluid-handling segment:



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(Dollars in millions)
Net sales	$	433.1		$	481.9		$	1,349.6		$	1,409.0
Gross profit	122.1			140.2			383.1			426.2
Gross profit margin	28.2		%	29.1		%	28.4		%	30.2		%
Asbestos coverage adjustment	$	8.2		$	—		$	8.2		$	—
Restructuring and other related charges	10.3			6.3			28.0			11.6
Selling, general and administrative expense	84.6			113.6			266.6			299.1
Selling, general and administrative expense as a percentage of Net sales	19.5		%	23.6		%	19.8		%	21.2		%
Segment operating income	$	29.3		$	26.6		$	108.3		$	127.1
Segment operating income margin	6.8		%	5.5		%	8.0		%	9.0		%

The $37.4 million Net sales decrease due to existing businesses during the third quarter of 2016 in comparison to the third quarter of 2015, as discussed and defined under “Sales, Orders and Backlog” above, was due to declines in our power generation, general industrial and other, oil, gas, and petrochemical, and marine end markets, partially offset by growth in our mining end market. Acquisition-related growth contributed $1.3 million of Net sales in the third quarter of 2016. Changes in foreign exchange rates had a negative impact on Net sales of $12.7 million. Gross profit and gross profit margin decreased in the third quarter of 2016 reflecting the impact of lower volumes and foreign exchange rates, partially offset by cost saving initiatives and acquisition-related growth. Gross profit for the third quarter of 2016 also included $3.2 million of inventory charges as a result of cyclical downturn in certain end markets. Restructuring and other related charges increased during the third quarter of 2016 primarily due to accelerated cost reduction programs to reduce our cost structure in response to the current challenging, cyclical economic conditions. Selling, general and administrative expense for the third quarter of 2016 decreased compared to the third quarter of 2015 primarily due to cost control activities and restructuring savings, and to a lesser extent, the impact of foreign exchange rates. These decreases were partially offset by a $1.9 million loss on deconsolidation of a Venezuelan subsidiary. Selling, general and administrative expense for the third quarter of 2015 includes $8.1 million of charges associated with uncollectible accounts of a specific customer in South America, $2.8 million of asset impairment charges, $3.3 million of transaction costs associated with the Roots Acquisition, and higher charges for revaluation of net asbestos-related liabilities.

The $65.8 million Net sales decrease due to existing businesses during the nine months ended September 30, 2016 in comparison to the nine months ended September 25, 2015, was due to declines in our power generation, marine, mining and general industrial and other end markets, partially offset by growth in our oil, gas, and petrochemical end markets. Acquisition-related growth contributed $51.6 million of Net sales during the nine months ended September 30, 2016. Changes in foreign exchange rates had a negative impact on Net sales of $45.2 million. Gross profit decreased in the nine months ended September 30, 2016 reflecting the impact of changes in volumes, foreign exchange rates, the inventory write-down discussed previously and a $3 million provision

for losses on customer contracts recorded in the second quarter. The decrease was partially offset by acquisition-related growth and a $1.1 million insurance recovery associated with a product liability claim recorded in the second quarter of 2016. Gross profit margin decreased during the nine months ended September 30, 2016 in comparison to the nine months ended September 25, 2015 due to decremental margins on lower volumes, contractual loss provisions, the inventory write-down and higher warranty costs. Restructuring and other related charges increased during the nine months ended September 30, 2016 primarily due to accelerated cost reduction programs. Selling, general and administrative expense for the nine months ended September 30, 2016 decreased compared to the nine months ended September 25, 2015 primarily due to changes in foreign exchange rates and cost control activities. The decrease was partially offset by acquisition-related growth and the loss on deconsolidation of our Venezuelan operation discussed previously, and a $1.4 million second quarter impairment charge on long-lived assets at a specific North American business. Also contributing to the year over year change were incremental charges in the third quarter of 2015 discussed previously.

During the third quarter of 2016, a Delaware Supreme Court ruling on September 12, 2016, affirmed prior rulings that an “all sums” allocation applies to a specific subsidiary’s insurance policies and that the subsidiary has rights under the excess insurance policies issued to a former owner of the business. The Court also ruled on other matters including specific determinations of coverage for defense costs under the excess policies. The net result of the ruling is an adjustment to our expected future recoveries, resulting in an $8.2 million reduction to the net recoverable insurance asset recorded as a charge to the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2016.

Fabrication Technology

We formulate, develop, manufacture and supply consumable products and equipment for use in the cutting and joining of steels, aluminum and other metals and metal alloys. Our fabrication technology products are marketed under several brand names, most notably ESAB and Victor, which we believe are well known in the international cutting and welding industry. ESAB’s comprehensive range of cutting and welding consumables includes electrodes, cored and solid wire and fluxes. ESAB’s fabrication technology equipment ranges from portable welding machines to large customized cutting and automated welding systems. Products are sold into a wide range of end markets, including oil, gas and petrochemicals, power generation, wind power, shipbuilding, pipelines, mobile/off-highway equipment and mining.

The following table summarizes selected financial data for our fabrication technology segment:



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(Dollars in millions)
Net sales	$	446.1		$	487.2		$	1,363.7		$	1,496.6
Gross profit	153.3			155.6			473.9			492.1
Gross profit margin	34.4		%	31.9		%	34.8		%	32.9		%
Restructuring and other related charges	$	6.9		$	6.8		$	21.4		$	14.1
Selling, general and administrative expense	105.3			113.3			325.5			338.5
Selling, general and administrative expense as a percentage of Net sales	23.6		%	23.3		%	23.9		%	22.6		%
Segment operating income	$	48.0		$	42.4		$	148.4		$	153.6
Segment operating income margin	10.8		%	8.7		%	10.9		%	10.3		%

The $28.5 million Net sales decrease due to existing businesses during the third quarter of 2016 in comparison to the third quarter of 2015, was primarily the result of decreases in volumes in North America, Europe and the Middle East, partially offset by growth in Russia and Asia. Additionally, changes in foreign exchange rates had a negative impact on Net sales of $12.6 million. Gross profit decreased in the third quarter of 2016 primarily due to the impact of lower volumes and changes in foreign exchange rates. Gross profit margin increased during the third quarter of 2016 in comparison to the third quarter of 2015 due to the positive impact of cost control activities. Restructuring and other related charges is consistent with the prior year as we continue to execute on programs to reduce our cost structure in response to the current challenging, cyclical economic conditions. The decrease in Selling, general and administrative expense in the third quarter of 2016 was primarily due to cost control activities and restructuring savings, and to a lesser extent, changes in foreign exchange rates. These decreases were partially offset by incremental legal costs of $3.7 million related to defense of alleged patent infringement and a $0.5 million loss on deconsolidation of our Venezuelan

operation. Selling, general and administrative expense for the third quarter of 2015 included $2.8 million of incremental charges associated with impairment of an intangible asset and an increase in the allowance for doubtful accounts.

The $59.8 million Net sales decrease due to existing businesses during the nine months ended September 30, 2016 in comparison to the nine months ended September 25, 2015, was primarily the result of a decrease in filler metal volumes in the Americas and Asia, and equipment volumes in North America, partially offset by three more business days in the nine months ended September 30, 2016 than the comparable 2015 period. Business days are more significant to fabrication technology where more products are sold from finished stock. Additionally, changes in foreign exchange rates had a negative impact on Net sales of $73.1 million. Gross profit decreased during the nine months ended September 30, 2016, primarily due to the impact of lower overall volumes and changes in foreign exchange rates partially offset by cost savings initiatives. Gross profit margin increased during the nine months ended September 30, 2016 in comparison to the nine months ended September 25, 2015 primarily due to decreased raw material costs and the positive impact of cost control activities. Restructuring and other related charges increased during the nine months ended September 30, 2016 due to the accelerated cost reduction programs mentioned previously. Selling, general and administrative expense decreased during the nine months ended September 30, 2016 as compared to the nine months ended September 25, 2015 as a result of savings from our cost reduction programs. These reductions were partially offset by net legal costs of $5.9 million related to defense of alleged patent infringement, the loss on deconsolidation of our Venezuelan operation discussed previously. The nine months ended September 30, 2016 also includes asset impairment charges of $2.3 million associated with the expected exit of a specific South American business and approximately $3.0 million of charges associated with uncollectible accounts of specific customers recorded during the first quarter of 2016.

Gross Profit - Total Company



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(Dollars in millions)
Gross profit	$	275.4		$	295.9		$	857.0		$	918.3
Gross profit margin	31.3		%	30.5		%	31.6		%	31.6		%

The $20.5 million decrease in Gross profit during the third quarter of 2016 in comparison to the third quarter of 2015 was attributable to a decreases of $18.2 million in our gas- and fluid-handling segment and $2.3 million in our fabrication technology segment. The $61.3 million decrease in Gross profit during the nine months ended September 30, 2016 in comparison to the nine months ended September 25, 2015 was attributable to decreases of $43.1 million in our gas- and fluid-handling segment and $18.2 million in our fabrication technology segment. Gross profit decreased during the third quarter and nine months ended September 30, 2016 in comparison to the third quarter and nine months ended September 25, 2015 primarily due to changes in foreign exchange rates, lower overall volumes and incremental inventory charges in the gas and fluid handling segment. Changes in foreign exchange rates during the third quarter and nine months ended September 30, 2016 had a $7.2 million and $32.9 million negative impact on Gross profit in comparison to the third quarter and nine months ended September 25, 2015. The cost savings and lower raw material prices in fabrication technology were more than sufficient to offset the impact of lower margins within gas- and fluid-handling and negative foreign exchange impact during the third quarter of 2016, resulting in an increase in gross profit margin for the quarter as compared to the third quarter of 2015. Gross profit margin was consistent for the nine months ended September 30, 2016 as compared to the nine months ended September 25, 2015 as the increase at fabrication technology was offset by the decrease in gas- and fluid-handling for reasons discussed previously. Gross profit for the third quarter and nine months ended September 25, 2015 also included various incremental charges discussed previously.

Operating Expenses - Total Company



	Three Months Ended						Nine Months Ended
	September 30, 2016			September 25, 2015			September 30, 2016			September 25, 2015
	(Dollars in millions)
Selling, general and administrative expense	$	199.5		$	237.2		$	627.4		$	673.1
Selling, general and administrative expense as a percentage of Net sales	22.7		%	24.5		%	23.1		%	23.2		%
Asbestos coverage adjustment	$	8.2		$	—		$	8.2		$	—
Restructuring and other related charges	17.2			13.1			49.3			25.7

Selling, general and administrative expense decreased by $37.7 million and $45.7 million during the third quarter and nine months ended September 30, 2016 in comparison to the third quarter and nine months ended September 25, 2015. The decreases in Selling, general and administrative expense are attributable to accelerated cost reduction programs in both segments and the impact of foreign exchange rates. These reductions were partially offset by acquisition related growth in our gas- and fluid-handling segment, incremental charges associated with uncollectible accounts of specific customers, asset impairments in specific operations in North and South America, legal costs related to defense of alleged patent infringement, and a $2.4 million loss on deconsolidation of our Venezuelan operations discussed previously. An $8.2 million net recoverable insurance asset reduction was recorded in the third quarter and nine months ended September 30, 2016 related to ongoing litigation for a specific subsidiary in our gas- and fluid-handling segment as discussed previously. Restructuring and other related charges increased during the third quarter and nine months ended September 30, 2016 primarily due to accelerated cost reduction programs to reduce our cost structure in response to the current challenging, cyclical economic conditions.

Interest Expense - Total Company



	Three Months Ended				Nine Months Ended
	September 30, 2016		September 25, 2015		September 30, 2016		September 25, 2015
	(In millions)
Interest expense	$	6.8	$	10.9	$	24.6	$	37.2

The decrease in Interest expense during the third quarter of 2016 as compared to the prior year was primarily due to lower foreign currency charges, interest income on a tax refund received in the current quarter, and lower amortization of deferred financing fees and original issue discount as a result of the refinancing of our credit facility in the prior year, all of which contributed approximate equal decreases to the change. For the nine months ended September 30, 2016, Interest expense declined as compared to the nine months ended September 25, 2015, primarily due to lower non-cash interest expense of $7.5 million due to the refinancing of our credit facility. Also contributing to the decline were lower foreign currency charges and the tax refund discussed previously.

Provision for Income Taxes - Total Company

The effective tax rate for the third quarter of 2016 was 26.3%, which was lower than the U.S. federal statutory tax rate primarily due to foreign earnings where international tax rates are lower than the U.S. tax rate, offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2016. The effective tax rate for the third quarter of 2015 was 32.1%, which was lower than the U.S. federal statutory tax rate primarily due to international tax rates, which are lower than the U.S. tax rate, offset in part by losses in certain jurisdictions where a tax benefit was not expected to be recognized in 2015.

The effective tax rate for the nine months ended September 30, 2016 was 30.6%, which was lower than the U.S. federal statutory tax rate primarily due to foreign earnings where international tax rates are lower than the U.S. tax rate and the impact of the U.S. based Asbestos coverage adjustment, offset in part by losses in certain jurisdictions where a tax benefit is not expected to be recognized in 2016. The effective tax rate for the nine months ended September 25, 2015 was 24.0%, which was lower than the U.S. federal statutory tax rate primarily due to a tax benefit of $13.0 million associated with the resolution of certain liabilities for unrecognized tax benefits and international tax rates, which are lower than the U.S. tax rate, offset in part by losses in certain jurisdictions where a tax benefit was not expected to be recognized in 2015.

Liquidity and Capital Resources

Overview

We have financed our capital and working capital requirements through a combination of cash flows from operating activities, borrowings under our bank credit facilities and the issuances of equity. We expect that our primary ongoing requirements for cash will be for working capital, funding of acquisitions, capital expenditures, asbestos-related cash outflows and funding of our pension plans. If determined appropriate for strategic acquisitions or other corporate purposes, we believe we could raise additional funds in the form of debt or equity.

Equity Capital

On October 11, 2015, the Company’s Board of Directors authorized the repurchase of up to $100.0 million of our Common stock from time-to-time on the open market or in privately negotiated transactions. The repurchase program is authorized until

December 31, 2016. The timing and amount of shares repurchased is to be determined by management based on its evaluation of market conditions and other factors.

During the nine months ended September 30, 2016, the Company repurchased 1,000,000 shares of the Company’s Common stock under a plan complying with Rule 10b5-1. As of September 30, 2016, the remaining stock repurchase authorization provided by the Company’s Board of Directors is approximately $52 million.

Borrowing Arrangements

On June 5, 2015, we entered into a Credit Agreement by and among the Company, as the borrower, certain U.S. subsidiaries of the Company identified therein, as guarantors, each of the lenders party thereto and Deutsche Bank AG New York Branch, as administrative agent, swing line lender and global coordinator, to extend the life of our borrowing facility to five years, adjust principal amortization, and modify the underlying covenants and security requirements.

As of September 30, 2016, the weighted-average interest rate of borrowings under the Credit Agreement was 1.92%, excluding accretion of original issue discount and deferred financing fees, and there was $779.4 million available on the revolving credit facility.

We are also party to letter of credit facilities with total capacity of $756.8 million. Total letters of credit of $352.5 million were outstanding as of September 30, 2016.

The Company is party to a receivables financing facility through a wholly-owned, special purpose bankruptcy-remote subsidiary which purchases trade receivables from certain of the Company’s subsidiaries on an ongoing basis and pledges them to support its obligation as borrower under the receivables financing facility. This special purpose subsidiary has a separate legal existence from its parent and its assets are not available to satisfy the claims of creditors of the selling subsidiaries or any other member of the consolidated group. Availability of funds may fluctuate over time given changes in eligible receivable balances, but will not exceed the program limit. On August 16, 2016, the program limit for the receivables financing facility decrased by $15 million from $95 million to $80 million. As of September 30, 2016, the total outstanding borrowings under the receivables financing facility were $76.6 million and the interest rate was 1.39%. The scheduled termination date for the receivables financing facility is December 20, 2016 and may be extended from time to time. The facility contains representations, warranties, covenants and indemnities customary for facilities of this type. The facility does not contain any covenants that the Company views as materially constraining to the activities of its business.

Certain U.S. subsidiaries of the Company have agreed to guarantee the obligations of the Company under the Credit Agreement. The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, incur debt or liens, merge or consolidate with others, dispose of assets or make certain investments. In addition, the Credit Agreement contains financial covenants requiring the Company to maintain a total leverage ratio, as defined therein, of not more than 3.5 to 1.0 and minimum interest coverage ratio, as defined therein, of 3.0 to 1.0, measured at the end of each quarter. The Credit Agreement contains various events of default (including failure to comply with the covenants under the Credit Agreement and related agreements) and upon an event of default the lenders may, subject to various customary cure rights, require the immediate payment of all amounts outstanding under the Term Loan and the Revolver. The Company is in compliance with all such covenants as of September 30, 2016. We believe that our sources of liquidity, including the Credit Agreement, are adequate to fund our operations for the next twelve months.

Cash Flows

As of September 30, 2016, we had $191.7 million of Cash and cash equivalents, a decrease of $5.8 million from $197.5 million as of December 31, 2015. The following table summarizes the change in Cash and cash equivalents during the periods indicated:



	Nine Months Ended
	September 30, 2016			September 25, 2015
	(In millions)
Net cash provided by operating activities	$	101.9		$	152.1
Purchases of fixed assets, net	(41.7		)	(32.7		)
Acquisition, net of cash received	—			(184.5		)
Net cash used in investing activities	(41.7		)	(217.2		)
(Repayments of) proceeds from borrowings, net	(44.9		)	19.6
Repurchases of common stock	(20.8		)	—
Proceeds from issuance of common stock, net	0.4			3.1
Other	(7.8		)	(9.8		)
Net cash (used in) provided by financing activities	(73.1		)	12.9
Effect of foreign exchange rates on Cash and cash equivalents	7.1			(32.0		)
Decrease in Cash and cash equivalents	$	(5.8	)	$	(84.2	)

Cash flows from operating activities can fluctuate significantly from period to period due to changes in working capital and the timing of payments for items such as pension funding and asbestos-related costs. Changes in significant operating cash flow items are discussed below.

•

Net cash received or paid for asbestos-related costs, net of insurance proceeds, including the disposition of claims, defense costs and legal expenses related to litigation against our insurers, creates variability in our operating cash flows. We had net cash outflows of $27.9 million and $10.5 million during the nine months ended September 30, 2016 and nine months ended September 25, 2015, respectively.

•

Funding requirements of our defined benefit plans, including pension plans and other post-retirement benefit plans, can vary significantly from period to period due to changes in the fair value of plan assets and actuarial assumptions. For the nine months ended September 30, 2016 and nine months ended September 25, 2015, cash contributions for defined benefit plans were $24.8 million and $32.6 million, respectively.


•	During the nine months ended September 30, 2016 and nine months ended September 25, 2015, cash payments of $44.4 million and $33.0 million, respectively, were made for our restructuring initiatives.

•

Changes in net working capital also affected the operating cash flows for the periods presented. We define working capital as Trade receivables, net and Inventories, net reduced by Accounts payable. During the nine months ended September 30, 2016, net working capital consumed cash of $93.2 million, before the impact of foreign exchange, primarily due to a decrease in payables and an increase in receivables, partially offset by a decrease in inventory. The principal contributor to the increase in working capital was lower billings in excess of revenues on long-term contracts as of September 30, 2016.

•

During the nine months ended September 25, 2015, net working capital consumed cash of $56.2 million, before the impact of foreign exchange, primarily due to an increase in receivables and inventory levels, partially offset by an increase in payables. The principal contributors to the increase in working capital in 2015 were higher inventory and receivable levels within the fabrication technology segment, and an increase in receivables in our gas- and fluid-handling segment.


•	Increased working capital in both years reflect normal seasonal changes.

The change in cash flows from investing activities for the nine months ended September 30, 2016 as compared to the nine months ended September 25, 2015 is primarily due to cash outflows for the Roots acquisition during the third quarter of 2015.

Cash flows from financing activities for the nine months ended September 30, 2016 were impacted by the repurchase of 1,000,000 shares of the Company’s Common stock for approximately $20.8 million and net repayments of borrowings of $44.9 million as compared to net borrowings of $19.6 million during the nine months ended September 25, 2015.

Our Cash and cash equivalents as of September 30, 2016 includes $187.3 million held in jurisdictions outside the U.S., which may be subject to U.S. income taxes if repatriated into the U.S. and other restrictions.

Critical Accounting Policies

The methods, estimates and judgments that we use in applying our critical accounting policies have a significant impact on our results of operations and financial position. We evaluate our estimates and judgments on an ongoing basis. Our estimates are based upon our historical experience, our evaluation of business and macroeconomic trends and information from other outside sources, as appropriate. Our experience and assumptions form the basis for our judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may vary from what our management anticipates and different assumptions or estimates about the future could have a material impact on our results of operations and financial position. There have been no significant additions to the methods, estimates and judgments included in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in our 2015 Form 10-K.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in short-term interest rates, foreign currency exchange rates and commodity prices that could impact our results of operations and financial condition. We address our exposure to these risks through our normal operating and financing activities. We do not enter into derivative contracts for trading purposes.

Interest Rate Risk

We are subject to exposure from changes in short-term interest rates related to interest payments on our borrowing arrangements. Under the Credit Agreement and the receivables financing facility, substantially all of our borrowings as of September 30, 2016 are variable-rate facilities based on LIBOR or EURIBOR. In order to mitigate our interest rate risk, we may enter into interest rate swap or collar agreements. A hypothetical increase in the interest rate of 1.00% during the third quarter and nine months ended September 30, 2016 would have increased Interest expense by approximately $3.5 million and $10.7 million, respectively.

Exchange Rate Risk

We have manufacturing sites throughout the world and sell our products globally. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar and against the currencies of other countries in which we manufacture and sell products and services. During the third quarter and nine months ended September 30, 2016, approximately 75% and 72% of our sales were derived from operations outside the U.S. We have significant manufacturing operations in European countries that are not part of the Eurozone. Sales revenues are more highly weighted toward the Euro and U.S. dollar. We also have significant contractual obligations in U.S. dollars that are met with cash flows in other currencies as well as U.S. dollars. To better match revenue and expense as well as cash needs from contractual liabilities, we regularly enter into cross currency swaps and forward contracts.

We also face exchange rate risk from our investments in subsidiaries owned and operated in foreign countries. The Euro denominated borrowings under the Credit Agreement provide a natural hedge to a portion of our European net asset position. The effect of a change in currency exchange rates on our net investment in international subsidiaries, net of the translation effect of the Company’s Euro denominated borrowings, is reflected in the Accumulated other comprehensive loss component of Equity. A 10% depreciation in major currencies, relative to the U.S. dollar as of September 30, 2016 (net of the translation effect of our Euro denominated borrowings) would result in a reduction in Equity of approximately $250 million.

We also face exchange rate risk from transactions with customers in countries outside the U.S. and from intercompany transactions between affiliates. Although we use the U.S. dollar as our functional currency for reporting purposes, we have manufacturing sites throughout the world, and a substantial portion of our costs are incurred and sales are generated in foreign

currencies. Costs incurred and sales recorded by subsidiaries operating outside of the U.S. are translated into U.S. dollars using exchange rates effective during the respective period. As a result, we are exposed to movements in the exchange rates of various currencies against the U.S. dollar. In particular, the Company has more sales in European currencies than it has expenses in those currencies. Although a significant portion of this difference is hedged, when European currencies strengthen or weaken against the U.S. dollar, operating profits are increased or decreased, respectively.

We have generally accepted the exposure to exchange rate movements without using derivative financial instruments to manage this risk. Both positive and negative movements in currency exchange rates against the U.S. dollar will, therefore, continue to affect the reported amount of sales, profit, assets and liabilities in our Condensed Consolidated Financial Statements.

Commodity Price Risk

We are exposed to changes in the prices of raw materials used in our production processes. Commodity futures contracts are periodically used to manage such exposure. As of September 30, 2016, our open commodity futures contracts were not material.

See Note 11, “Financial Instruments and Fair Value Measurements” in our Notes to Condensed Consolidated Financial Statements included in this Form 10-Q for additional information regarding our derivative instruments.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of September 30, 2016. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective in providing reasonable assurance that the information required to be disclosed in this report on Form 10-Q has been recorded, processed, summarized and reported as of the end of the period covered by this report on Form 10-Q.

Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f)) identified in connection with the evaluation required by Rule 13a-15(d) of the Exchange Act that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

Discussion of legal proceedings is incorporated by reference to Note 12, “Commitments and Contingencies,” in the Notes to Condensed Consolidated Financial Statements included in Part I. Item 1. “Financial Statements” of this Form 10-Q.

Item 1A. Risk Factors

An investment in our common stock involves a high degree of risk. There have been no material changes to the risk factors included in “Part I. Item 1A. Risk Factors” in our 2015 Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On October 11, 2015, the Company’s Board of Directors authorized the repurchase of up to $100.0 million of the Company’s Common stock from time-to-time on the open market or in privately negotiated transactions. The repurchase program is authorized until December 31, 2016 and is being conducted pursuant to SEC Rule 10b-18. The timing and amount of shares repurchased is to be determined by management based on its evaluation of market conditions and other factors. For the three months ended September 30, 2016 the Company made no repurchases of shares. The following table presents additional information with respect to our Common stock repurchase program.



Period	Total Number of Shares Purchased	Average Price Paid per Share	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased under the Plans or Programs
7/2/16 - 7/29/16	—	—	—	51,821,526
7/30/16 - 8/26/16	—	—	—	51,821,526
8/27/16 - 9/30/16	—	—	—	51,821,526
Total	—	—	—	51,821,526	⁽¹⁾


⁽¹⁾	Represents the repurchase program limit authorized by the Board of Directors of $100.0 million less the value of purchases made since October 11, 2015.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits



Exhibit No.	Exhibit Description

3.01*	Amended and Restated Certificate of Incorporation.

3.02**	Colfax Corporation Amended and Restated Bylaws.

31.01	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.02	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.01	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.02	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS	XBRL Instance Document

101.SCH	XBRL Taxonomy Extension Schema Document

101.CAL	XBRL Extension Calculation Linkbase Document

101.DEF	XBRL Taxonomy Extension Definition Linkbase Document

101.LAB	XBRL Taxonomy Extension Label Linkbase Document

101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document

*	Incorporated by reference to Exhibit 3.01 to Colfax Corporation’s Form 8-K (File No. 001-34045) as filed with the SEC on January 30, 2012.
**	Incorporated by reference to Exhibit 3.02 to Colfax Corporation’s Form 10-Q (File No. 001-34045) as filed with the SEC on July 23, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Registrant: Colfax Corporation

By:



/s/ Matthew L. Trerotola	President and Chief Executive Officer
Matthew L. Trerotola	(Principal Executive Officer)	October 27, 2016

/s/ Christopher M. Hix	Senior Vice President, Finance,
Christopher M. Hix	Chief Financial Officer and Treasurer	October 27, 2016
	(Principal Financial and Accounting Officer)